Showing results (201-210 of 234) with videos related to

Sort By:
Pageof 24
European Journal of Nuclear Medicine and Molecular Imaging|June 30, 2019
[18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's diseaseSandra Sanabria Bohórquez, Jan Marik, Annie Ogasawara, et al.
Alzheimer'S Research & Therapy|September 21, 2018
Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer's disease (BLAZE)Stephen Salloway, Lee A Honigberg, William Cho, et al.
The Journal of Biological Chemistry|June 6, 2003
Transcriptional regulation of biomass-degrading enzymes in the filamentous fungus Trichoderma reeseiPamela K Foreman, Doug Brown, Lydia Dankmeyer, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2026
Lysosomal escape and TMEM106B fibrillar core determine TDP-43 seeding outcomesWeijia Zhong, Carlo Scialò, Beatrice Gatta, et al.
Reproductive Biology and Endocrinology : RB&E|March 10, 2010
Alterations in the steroid hormone receptor co-chaperone FKBPL are associated with male infertility: a case-control studyOlaf Sunnotel, Laszlo Hiripi, Kevin Lagan, et al.
Toxins|March 4, 2020
Inhibitory Effects of a Reengineered Anthrax Toxin on Canine Oral Mucosal MelanomasAdriana Tomoko Nishiya, Marcia Kazumi Nagamine, Ivone Izabel Mackowiak da Fonseca, et al.
Nature Medicine|March 5, 2026
The TREM2 agonistic antibody AL002 in early Alzheimer's disease: a phase 2 randomized trialCatherine J Mummery, Arthur J Mayorga, Adam Simmons, et al.
Biorxiv : the Preprint Server for Biology|October 1, 2025
Generation of C9orf72 repeat knock-in iPSC lines for modelling ALS and FTDRachel Coneys, Alexander J Cammack, Remya R Nair, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 23, 2023
Impact of Introducing Infliximab Biosimilars on Total Infliximab Consumption and Originator Infliximab Prices in Eight Regions: An Interrupted Time-Series AnalysisKuan Peng, Joseph E Blais, Nicole L Pratt, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2018
The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical PSEN1 E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer's disease, including a placebo-treated noncarrier cohortPierre N Tariot, Francisco Lopera, Jessica B Langbaum, et al.
Pageof 24